Portage Biotech Inc. (NASDAQ: PRTG)
$0.18
+0.0013 ( +0.72% ) 580.1K
Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through to clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.
Market Data
Open
$0.18
Previous close
$0.18
Volume
580.1K
Market cap
$3.76M
Day range
$0.17 - $0.20
52 week range
$0.13 - $3.60
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
6-k | Quarterly Reports | 26 | Nov 13, 2023 |
6-k | Quarterly Reports | 11 | Oct 03, 2023 |
6-k | Quarterly Reports | 2 | Sep 29, 2023 |
6-k | Quarterly Reports | 26 | Sep 08, 2023 |
6-k | Quarterly Reports | 2 | Aug 30, 2023 |
6-k | Quarterly Reports | 90 | Aug 29, 2023 |
6-k | Quarterly Reports | 26 | Aug 14, 2023 |
6-k | Quarterly Reports | 2 | Aug 01, 2023 |
20-f | Annual reports | 221 | Jul 31, 2023 |